In a new report this week, the FDA highlighted several serious adverse events and deaths associated with the drug Librela. The drug's maker, however, claims that it remains safe and effective.

The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse reactions.

The warning was issued for Librela, which is a painkiller commonly given to dogs to relieve arthritis pain. The drug is administered by a vet once a month via subcutaneous injection. The FDA has said that dogs on Librela may experience dangerous side effects, such as: Seizures. Loss of muscle control . Urinary incontinence. Death.